Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study

PLoS Medicine

Volumn 10, Issue 4, 2013, Pages

  Langan, Sinéad M ^a   Smeeth, Liam ^a   Margolis, David J ^b   Thomas, Sara L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE;

AGE; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DISEASE CLASSIFICATION; DRUG EFFICACY; FEMALE; HERPES ZOSTER; IMMUNE DEFICIENCY; INCIDENCE; INCOME; MAJOR CLINICAL STUDY; MALE; NEURALGIA; OUTCOME ASSESSMENT; RACE; VACCINATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INCOME; MALE; NEURALGIA, POSTHERPETIC; PROPORTIONAL HAZARDS MODELS; UNITED STATES; VACCINATION;

EID: 84876897193     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001420     Document Type: Article

References (17)

1. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, et al. (2007) A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82: 1341-1349.
2. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, et al. (2010) The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 8: 37.
3. Oxman M, Levin M, Johnson G, Schmader K, Straus S, et al. (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352: 2271-2284.
4. Schmader KE, Levin MJ, Gnann JW, McNeil SA, Vesikari T, et al. (2012) Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 54: 922-928.
5. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, et al. (2011) Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 305: 160-166.
6. Zhang J, Xie F, Delzell E, Chen L, Winthrop KL, et al. (2012) Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 308: 43-49.
7. Harpaz R, Ortega-Sanchez I, Seward J, (2008) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57: 1-30; quiz CE32-34.
8. Gebo K, Kalyani R, Moore R, Polydefkis M, (2005) The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr 40: 169-174.
9. Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, et al. (2009) Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 301: 737-744.
10. Gourishankar S, McDermid J, Jhangri G, Preiksaitis J, (2004) Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 4: 108-115.
11. Son M, Shapiro ED, LaRussa P, Neu N, Michalik DE, et al. (2010) Effectiveness of varicella vaccine in children infected with HIV. J Infect Dis 201: 1806-1810.
12. Gershon AA, Levin MJ, Weinberg A, Song LY, LaRussa PS, et al. (2009) A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella. Pediatr Infect Dis J 28: 653-655.
13. Center for Medicare and Medicaid Services (2009) Center for Medicare and Medicaid Services 2009 data compendium. Baltimore (Maryland): Center for Medicare and Medicaid Services.
14. Klompas M, Kulldorff M, Vilk Y, Bialek SR, Harpaz R, (2011) Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clin Proc 86: 1146-1153.
15. Thomas S, Hall A, (2004) What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 4: 26-33.
16. Yawn BP, Wollan P, St Sauver J, (2011) Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol 174: 1054-1061.
17. Donahue J, Choo P, Manson J, Platt R, (1995) The incidence of herpes zoster. Arch Intern Med 155: 1605-1609.